Immunoglobulin Market Projected To Garner Significant Revenues By 2025

Posted by sanjayhande on November 21st, 2019

Surge in geriatric population who are hemophilic, increase in immunoglobulin production using advanced technologies, and use of enhanced purification techniques with better plasma yield drive the growth of the global immunoglobulin market. Furthermore, increase in incidence of diseases such as chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, and others supplement the market growth. However, stringent government regulations for immunoglobulin products and side effects associated with the use of immunoglobulin hamper the market growth.

As per the report, the global immunoglobulin market garnered $ 9,972.9 million in 2017, and is estimated to reach $ 16,694.7 Million by 2025, registering a CAGR of 6.6% from 2018 to 2025.

Click Here To Access The Sample Report @ https://www.alliedmarketresearch.com/request-sample/2586

Hypogammaglobulinemia segment to dominate in terms of revenue by 2025 
Among applications, hypogammaglobulinemia segment contributed the highest market share of 21% in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to the growing incidence of hypogammaglobulinemia worldwide. However, myasthenia gravis segment is projected to grow at the fastest CAGR of 9.4% from 2018 to 2025. The report also analyzes chronic inflammatory demyelinating polyneuropathy, primary Immunodeficiency diseases, multifocal motor neuropathy, ITP, inflammatory myopathies, specific antibody deficiency, Guillain-Barre syndrome and others segments.

Intravenous segment to dominate through the forecast period 
Among various modes of delivery, the intravenous segment accounted for 90% share of the total market revenue in 2017 and is expected to maintain its dominance through the study period. High bioavailability of immunoglobulins and rapid absorption rate offered by intravenous mode of delivery drive the growth of this segment. On the other hand, the suncutaneous segment would grow at the fastest CAGR of 6.6% during the forecast period.

North America: highest revenue-generating region, LAMEA: fastest growing segment 

North America contributed nearly half of the total market share in 2017 and would continue to maintain its dominance through 2025. The presence of large plasma production units and high adoption of immunoglobulin in the region boost the market growth. However, Latin America, Middle East and Africa (LAMEA) would register the highest CAGR of 9.4% from 2018 to 2025. The other regions analyzed in the study include Asia-Pacific and Europe.

The report presents a detailed analysis of the key players of the global immunoglobulin market including:

• Baxter international Inc.
• CSL Ltd.
• Grifols S.A
• Octapharma AG
• Kedrion Biopharma Inc.
• LFB group
• Biotest AG
• China Biologics Products Inc.
• Shire (Baxalta)
• Bayer Healthcare

These players have adopted new product launches, joint ventures, expansions, mergers & acquisitions, partnerships, and collaborations to gain stronghold in the industry.

Obtain Report Details: https://www.alliedmarketresearch.com/immunoglobulin-market

About Us 
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.